Table 1:

Characteristics of patients enrolled.

	Total Population (n=59)	Control Arm (n=21)	7-day Supplementation (n=18)	14-day Supplementation (n=20)
Age, median	59 yrs	59 yrs	59.5 yrs	59.5
range	42–77 yrs	42–71 yrs	43–77 yrs	48–70 yrs
Race
White	47	16	14	17
Black	8	4	2	2
Asian	4	1	2	1
Median Baseline PSA, ng/mL	5.16	5.14	5.45	4.2
range, ng/mL	1–53.7	2.2–53.7	1–22.14	2.1–10.2
Median PSA on Day of Surgery, ng/mL	4.8	6.62	4.53	4.51
range, ng/mL	0.8–47.25	2.11–47.25	2–19.42	0.8–10.87
Pre-operative Gleason Score, median	6	6	7	7
Range	6–10	6–9	6–10	6–9
3+3	29	14	8	7
3+4	18	6	5	7
4+3	4	-	1	3
4+4	5	-	3	2
4+5	1	-	-	1
5+4	1	1	-	-
5+5	1	-	1	-